1-3 of 3
Josefa Chuh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models

Suzie J. Scales, Nidhi Gupta, Glenn Pacheco, Ron Firestein, Dorothy M. French, Hartmut Koeppen, Linda Rangell, Vivian Barry-Hamilton, Elizabeth Luis, Josefa Chuh, Yin Zhang, Gladys S. Ingle, Aimee Fourie-O'Donohue, Katherine R. Kozak, Sarajane Ross, Mark S. Dennis, Susan D. Spencer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2630–2640.
https://doi.org/10.1158/1535-7163.MCT-14-0487-T
Published: 03 November 2014
View article titled, An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
Open the PDF for An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models in another window
Includes: Supplementary data
Journal Articles

DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

Dongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, Randall Dere, MaryAnn Go, Jeffrey Lau, Bing Zheng, Kristi Elkins, Dimitry Danilenko, Katherine R. Kozak, Pamela Chan, Josefa Chuh, Xiaoyan Shi, Denise Nazzal, Franklin Fuh, Jacqueline McBride, Vanitha Ramakrishnan, Ruth de Tute, Andy Rawstron, Andrew S. Jack, Rong Deng, Yu-Waye Chu, David Dornan, Marna Williams, William Ho, Allen Ebens, Saileta Prabhu, Andrew G. Polson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (7): 1255–1265.
https://doi.org/10.1158/1535-7163.MCT-12-1173
Published: 07 July 2013
View article titled, DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
Open the PDF for DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates

Bing Zheng, Reina N. Fuji, Kristi Elkins, Shang-Fan Yu, Franklin K. Fuh, Josefa Chuh, Christine Tan, Jo-Anne Hongo, Helga Raab, Katherine R. Kozak, Marna Williams, Elena McDorman, Dan Eaton, Allen Ebens, Andrew G. Polson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2937–2946.
https://doi.org/10.1158/1535-7163.MCT-09-0369
Published: 12 October 2009
View article titled, <em>In vivo</em> effects of targeting CD79b with antibodies and antibody-drug conjugates
Open the PDF for <em>In vivo</em> effects of targeting CD79b with antibodies and antibody-drug conjugates in another window